GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncimmune Holdings PLC (LSE:ONC) » Definitions » Market Cap

Oncimmune Holdings (LSE:ONC) Market Cap : £13.23 Mil (As of Jun. 05, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Oncimmune Holdings Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Oncimmune Holdings's share price for the quarter that ended in Feb. 2024 was £0.215. Oncimmune Holdings's Shares Outstanding (EOP) for the quarter that ended in Feb. 2024 was 74.14 Mil. Therefore, Oncimmune Holdings's market cap for the quarter that ended in Feb. 2024 was £15.94 Mil.

Oncimmune Holdings's quarterly market cap declined from Feb. 2023 (£26.10 Mil) to Aug. 2023 (£17.20 Mil) and declined from Aug. 2023 (£17.20 Mil) to Feb. 2024 (£15.94 Mil).

Oncimmune Holdings's annual market cap declined from May. 2021 (£144.12 Mil) to May. 2022 (£67.74 Mil) and declined from May. 2022 (£67.74 Mil) to Aug. 2023 (£17.20 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Oncimmune Holdings's Enterprise Value for Today is £17.59 Mil.


Oncimmune Holdings Market Cap Historical Data

The historical data trend for Oncimmune Holdings's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncimmune Holdings Market Cap Chart

Oncimmune Holdings Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 Aug23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 58.51 70.17 144.12 67.74 17.20

Oncimmune Holdings Semi-Annual Data
May14 Nov14 May15 Nov15 May16 Nov16 May17 Nov17 May18 Nov18 May19 Nov19 May20 Nov20 May21 Nov21 May22 Feb23 Aug23 Feb24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 117.87 67.74 26.10 17.20 15.94

Competitive Comparison of Oncimmune Holdings's Market Cap

For the Biotechnology subindustry, Oncimmune Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oncimmune Holdings's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oncimmune Holdings's Market Cap distribution charts can be found below:

* The bar in red indicates where Oncimmune Holdings's Market Cap falls into.



Oncimmune Holdings Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Oncimmune Holdings's Market Cap for the fiscal year that ended in Aug. 2023 is calculated as

Market Cap (A: Aug. 2023 )=Share Price (A: Aug. 2023 )*Shares Outstanding (EOP) (A: Aug. 2023 )
=£0.232*74.1422
=£17.20

Oncimmune Holdings's Market Cap for the quarter that ended in Feb. 2024 is calculated as

Market Cap (Q: Feb. 2024 )=Share Price (Q: Feb. 2024 )*Shares Outstanding (EOP) (Q: Feb. 2024 )
=£0.215*74.1422
=£15.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oncimmune Holdings  (LSE:ONC) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Oncimmune Holdings Market Cap Related Terms

Thank you for viewing the detailed overview of Oncimmune Holdings's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Oncimmune Holdings (LSE:ONC) Business Description

Traded in Other Exchanges
Address
1 Park Row, MediCity - D6 Building, Leeds, GBR, LS1 5AB
Oncimmune Holdings PLC is engaged in diagnosing cancer. It is involved in the development, manufacture, and commercialization of personalized immunodiagnostics for the screening, detection and care of cancer. The company's operating segment includes Early CDT Lung and ImmunoINSIGHTS.

Oncimmune Holdings (LSE:ONC) Headlines

No Headlines